Building great technology isn’t enough. Many startups focus on product development and regulatory approval, only to struggle raising funding because investors don’t see a clear path to market. The key to success? A believable go-to-market strategy early in your journey. In this session, I’ll share lessons from MedTech startups — including one that failed despite FDA clearance — and show practical steps to integrate commercial planning, de-risk your startup, and win investor confidence before launch. Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/.
The Bench2Market Talks series is created to provide commercialization guidance to the university research community. For more details on the series, visit our website at https://biolocity.gatech.edu/news-and-events/b2m-talks/.
Powered by WordPress & Theme by Anders Norén
You must be logged in to post a comment.